Follow-up of oral cancer patients: three uneventful years may be enough

Sharon J Taslim; C René Leemans; Isaäc van der Waal; K H Karagozoglu

doi:10.1016/j.oooo.2016.05.009

Follow-up of oral cancer patients: three uneventful years may be enough

Sharon J Taslim, C René Leemans, Isaäc van der Waal, K H Karagozoglu

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

OBJECTIVE: To explore the possibility of shortening the length of follow-up from 5 to 3 years in patients who have undergone curative treatment of an oral squamous cell carcinoma.

STUDY DESIGN: The medical records of 225 patients who had undergone initial curative treatment at the VU University Medical Center in Amsterdam, the Netherlands, between 2004 and 2009 were analyzed.

RESULTS: In 96 patients (42.7%) a secondary event occurred. Eighty-six percent of the secondary events were detected within 3 years. In the fourth and fifth years, 14% of the secondary events were found, consisting mainly of second primary tumors.

CONCLUSIONS: Most secondary events occurred within the first 3 years of follow-up. Therefore, the case can be made for an altered regimen of follow-up beyond 3 years based on certain risk factors unique to the patient as well as the patient's ability to adequately report symptoms that may be associated with recurrent disease.

Original language	English
Pages (from-to)	434-9
Number of pages	6
Journal	Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics
Volume	122
Issue number	4
DOIs	https://doi.org/10.1016/j.oooo.2016.05.009
Publication status	Published - 2016

Access to Document

10.1016/j.oooo.2016.05.009

Cite this

@article{cae7af94ca56498e8dcc6bc4b535e172,

title = "Follow-up of oral cancer patients: three uneventful years may be enough",

abstract = "OBJECTIVE: To explore the possibility of shortening the length of follow-up from 5 to 3 years in patients who have undergone curative treatment of an oral squamous cell carcinoma.STUDY DESIGN: The medical records of 225 patients who had undergone initial curative treatment at the VU University Medical Center in Amsterdam, the Netherlands, between 2004 and 2009 were analyzed.RESULTS: In 96 patients (42.7%) a secondary event occurred. Eighty-six percent of the secondary events were detected within 3 years. In the fourth and fifth years, 14% of the secondary events were found, consisting mainly of second primary tumors.CONCLUSIONS: Most secondary events occurred within the first 3 years of follow-up. Therefore, the case can be made for an altered regimen of follow-up beyond 3 years based on certain risk factors unique to the patient as well as the patient's ability to adequately report symptoms that may be associated with recurrent disease.",

keywords = "Journal Article",

author = "Taslim, {Sharon J} and Leemans, {C Ren{\'e}} and {van der Waal}, Isa{\"a}c and Karagozoglu, {K H}",

year = "2016",

doi = "10.1016/j.oooo.2016.05.009",

language = "English",

volume = "122",

pages = "434--9",

journal = "Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics",

issn = "1079-2104",

number = "4",

}

TY - JOUR

T1 - Follow-up of oral cancer patients

T2 - three uneventful years may be enough

AU - Taslim, Sharon J

AU - Leemans, C René

AU - van der Waal, Isaäc

AU - Karagozoglu, K H

PY - 2016

Y1 - 2016

N2 - OBJECTIVE: To explore the possibility of shortening the length of follow-up from 5 to 3 years in patients who have undergone curative treatment of an oral squamous cell carcinoma.STUDY DESIGN: The medical records of 225 patients who had undergone initial curative treatment at the VU University Medical Center in Amsterdam, the Netherlands, between 2004 and 2009 were analyzed.RESULTS: In 96 patients (42.7%) a secondary event occurred. Eighty-six percent of the secondary events were detected within 3 years. In the fourth and fifth years, 14% of the secondary events were found, consisting mainly of second primary tumors.CONCLUSIONS: Most secondary events occurred within the first 3 years of follow-up. Therefore, the case can be made for an altered regimen of follow-up beyond 3 years based on certain risk factors unique to the patient as well as the patient's ability to adequately report symptoms that may be associated with recurrent disease.

AB - OBJECTIVE: To explore the possibility of shortening the length of follow-up from 5 to 3 years in patients who have undergone curative treatment of an oral squamous cell carcinoma.STUDY DESIGN: The medical records of 225 patients who had undergone initial curative treatment at the VU University Medical Center in Amsterdam, the Netherlands, between 2004 and 2009 were analyzed.RESULTS: In 96 patients (42.7%) a secondary event occurred. Eighty-six percent of the secondary events were detected within 3 years. In the fourth and fifth years, 14% of the secondary events were found, consisting mainly of second primary tumors.CONCLUSIONS: Most secondary events occurred within the first 3 years of follow-up. Therefore, the case can be made for an altered regimen of follow-up beyond 3 years based on certain risk factors unique to the patient as well as the patient's ability to adequately report symptoms that may be associated with recurrent disease.

KW - Journal Article

U2 - 10.1016/j.oooo.2016.05.009

DO - 10.1016/j.oooo.2016.05.009

M3 - Article

C2 - 27496578

VL - 122

SP - 434

EP - 439

JO - Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics

JF - Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics

SN - 1079-2104

IS - 4

ER -